Literature DB >> 12520541

Mechanisms of intestinal calcium absorption.

Felix Bronner1.   

Abstract

Calcium is absorbed in the mammalian small intestine by two general mechanisms: a transcellular active transport process, located largely in the duodenum and upper jejunum; and a paracellular, passive process that functions throughout the length of the intestine. The transcellular process involves three major steps: entry across the brush border, mediated by a molecular structure termed CaT1, intracellular diffusion, mediated largely by the cytosolic calcium-binding protein (calbindinD(9k) or CaBP); and extrusion, mediated largely by the CaATPase. Chyme travels down the intestinal lumen in approximately 3 h, spending only minutes in the duodenum, but over 2 h in the distal half of the small intestine. When calcium intake is low, transcellular calcium transport accounts for a substantial fraction of the absorbed calcium. When calcium intake is high, transcellular transport accounts for only a minor portion of the absorbed calcium, because of the short sojourn time and because CaT1 and CaBP, both rate-limiting, are downregulated when calcium intake is high. Biosynthesis of CaBP is fully and CaT1 function is approximately 90% vitamin D-dependent. At high calcium intakes CaT1 and CaBP are downregulated because 1,25(OH)(2)D(3), the active vitamin D metabolite, is downregulated. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12520541     DOI: 10.1002/jcb.10330

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  53 in total

Review 1.  Chymotrypsin C mutations in chronic pancreatitis.

Authors:  Jiayi Zhou; Miklós Sahin-Tóth
Journal:  J Gastroenterol Hepatol       Date:  2011-08       Impact factor: 4.029

Review 2.  The epithelial calcium channels TRPV5 and TRPV6: regulation and implications for disease.

Authors:  Monique van Abel; Joost G J Hoenderop; René J M Bindels
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-04       Impact factor: 3.000

3.  25-Hydroxyvitamin D level does not reflect intestinal calcium absorption: an assay using strontium as a surrogate marker.

Authors:  Marília Brasilio Rodrigues Camargo; Tatiane Vilaça; Lilian Fukusima Hayashi; Olguita G Ferreira Rocha; Marise Lazaretti-Castro
Journal:  J Bone Miner Metab       Date:  2014-05-24       Impact factor: 2.626

4.  Apical GLUT2 and Cav1.3: regulation of rat intestinal glucose and calcium absorption.

Authors:  Emma L Morgan; Oliver J Mace; Julie Affleck; George L Kellett
Journal:  J Physiol       Date:  2007-02-01       Impact factor: 5.182

5.  Calcium absorption by Cav1.3 induces terminal web myosin II phosphorylation and apical GLUT2 insertion in rat intestine.

Authors:  Oliver J Mace; Emma L Morgan; Julie A Affleck; Norma Lister; George L Kellett
Journal:  J Physiol       Date:  2007-02-01       Impact factor: 5.182

6.  Hypercalcemic States associated with nephrolithiasis.

Authors:  Brandon L Craven; Corey Passman; Dean G Assimos
Journal:  Rev Urol       Date:  2008

7.  Immobilization decreases duodenal calcium absorption through a 1,25-dihydroxyvitamin D-dependent pathway.

Authors:  Tadatoshi Sato; Hironori Yamamoto; Naoki Sawada; Kunitaka Nashiki; Mitsuyoshi Tsuji; Takeshi Nikawa; Hidekazu Arai; Kyoko Morita; Yutaka Taketani; Eiji Takeda
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

8.  Transcellular calcium transport in mammary epithelial cells.

Authors:  Joshua N VanHouten; John J Wysolmerski
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-11-13       Impact factor: 2.673

9.  Inherited disorders of calcium and phosphate metabolism.

Authors:  Jyothsna Gattineni
Journal:  Curr Opin Pediatr       Date:  2014-04       Impact factor: 2.856

10.  Exploration of intestinal calcium precipitation as a barrier to absorption at high calcium doses.

Authors:  Sandra Goss; Pauline Rafferty; Jennifer Prushko; Eric Gorman; Mitchell Taub; Robin Bogner
Journal:  Pharm Res       Date:  2008-06-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.